EICHORPublic-registry site landscape for NCT03677648, “A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease”, a Crohn's Disease study sponsored by Reistone Biopharma Company Limited. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03677648 (registry record) |
| Study title | A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease |
| Official title | A Phase II Randomized, Placebo Controlled, Double-blind, Four Arms Dose-ranging Study to Evaluate the Efficacy and Safety of SHR0302 Compared to Placebo in Patients With Moderate to Severe Active Crohn's Disease |
| Sponsor | Reistone Biopharma Company Limited |
| Condition(s) | Crohn's Disease |
| Phase | PHASE2 |
| Listed sites | 82 |
| Site countries | United States, China, Poland, Ukraine |
Patient-friendly overview of this study: eichor.com/study/NCT03677648.
Eichor generates a preliminary site-risk snapshot for NCT03677648 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Crohn's Disease trials
← Eichor home · All tracked trials · Crohn's Disease studies · Weekly briefs
